Targeted agents in cancer
Autor: | Joanita Ocen, Satish Kumar |
---|---|
Rok vydání: | 2020 |
Předmět: |
Chemotherapy
business.industry Cell growth medicine.medical_treatment Cancer General Medicine medicine.disease Biomarker (cell) Targeted therapy Radiation therapy 03 medical and health sciences 0302 clinical medicine Apoptosis 030220 oncology & carcinogenesis Cancer cell medicine Cancer research 030212 general & internal medicine business |
Zdroj: | Medicine. 48:108-112 |
ISSN: | 1357-3039 |
DOI: | 10.1016/j.mpmed.2019.11.008 |
Popis: | Non-cytotoxic systemic treatments are a major component of systemic anti-cancer treatment. Targeted therapies are used to treat multiple tumour sites in both potentially curative and palliative settings and can be used in combination with chemotherapy, surgery and radiotherapy. Agents may have specific or multiple targets inhibiting cellular proliferation and cell growth and inducing cellular arrest and apoptosis. Patients must be closely observed on treatment; side effects can be class- or agent-specific. Despite high activity levels, cancer cells eventually develop mechanisms of resistance against targeted therapy. |
Databáze: | OpenAIRE |
Externí odkaz: |